ArticleLight, science & applications2026
Optical coherence photoacoustic microscopy for 3D cancer model imaging with AI-assisted organoid analysis.
Article in Light, science & applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Organoid Intelligent Morphomics: Decoding the organoid morphome through artificial intelligence from phenotypic quantification to mechanistic insight.Bioactive materials · 2027Review
- Real-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.Bioactive materials · 2026Review
- Effective point spread function modeling of photoacoustic remote sensing microscopy towards resolution enhancement.Photoacoustics · 2026Article
- Photoacoustic Imaging for Women's Gynecological Health: Advances and Clinical Prospects.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Cancer organoids and cancer spheroids are 3D cell culture models with distinct yet overlapping purposes in cancer research. Various commercially available optical imaging techniques have been employed to study these cell cultures, but these methods suffer from various limitations such as the requirement of fluorescence labeling, complicated sample handling, and limited image volume size. In this work, we demonstrate a multimodal optical coherence photoacoustic microscopy (OC-PAM) system for the study of these models, overcoming these limitations. We first performed a longitudinal study using optical coherence microscopy (OCM) for breast cancer organoids. Using the OCM imaging results, artificial intelligence (AI)-based algorithms were developed to automatically segment individual organoids and classify their viability over time using a radiomics texture feature approach, enabling robust, quantitative tracking and classification at the single-organoid level. To supplement OCM's contrast, we then performed OC-PAM imaging of spheroid models with both melanin positive and melanin negative cells. In the second study, the OC-PAM images clearly mapped the distribution of melanin positive cells hidden amongst melanin negative cells. These results suggest that OC-PAM coupled with AI techniques can be a powerful tool to study cancer organoids and cancer spheroids.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.